Latest Integration News

CuFe Ltd has boosted confidence in its Orlando Copper-Gold Deposit by upgrading 87% of the resource to Indicated, paving the way for development studies and a substantial drilling campaign.

Zeotech pushed forward its AusPozz™ metakaolin commercialisation with extended and new MOUs, progressed key Toondoon project approvals amid rising contractor costs, and launched live methane control trials.

Argent BioPharma secured a 48% stake in CannPal Animal Therapeutics, shipped its largest CannEpil® order to Ireland worth A$783,000, and filed a US provisional patent for its NanoBodies platform, underpinning its neuro-immune strategy and commercial growth.

Mt Malcolm Mines has delivered a maiden Mineral Resource Estimate of 13,200 ounces across Golden Crown and Dumbarton, while advancing a study on refurbishing a 500,000 tpa CIP plant and preparing for follow-up drilling and funding.

GCM Corporation finalises exclusive rights to its Very High Density technology, launches its first commercial heat sink products, and expands global prototyping efforts targeting high-growth sectors including EV infrastructure and data centres.

Southern Palladium reported a doubling in chromite recoveries at its Bengwenyama project, prompting a redesign of the processing plant and pushing the DFS completion to late Q4 2026 amid drilling delays and enhanced metallurgical work.

Kalgoorlie Gold Mining has confirmed gold mineralisation extending to 300 metres depth at its Pinjin Gold Project, triggering its most ambitious drilling campaign to date, including extensive RC, diamond, and aircore programs.

Cosmos Exploration is advancing its Bolivian lithium ambitions by exercising its option to acquire 100% of EAU Lithium and raising A$5 million to fund exploration and acquisition costs.

Resonance Health reports strong cash flow and progress in clinical trials, with a record forward order pipeline for its Software-as-a-Medical-Device business and profitable trial site clinics.

Axel REE has selected its Woolrich deposit for inaugural in situ recovery (ISR) field trials, backed by metallurgical breakthroughs doubling gallium extraction and confirming scandium co-recovery, positioning Caladão as a rare dual-pathway rare earth project.

HyTerra Ltd is progressing its flagship Nemaha hydrogen project with a key production test planned for Q2 2026, while expanding its global footprint through strategic partnerships and a $7 million capital raise.

Botanix Pharmaceuticals reported a 5% rise in Sofdra prescriptions in Q3 FY26 despite a dip in net revenue due to insurance deductible resets, strengthened by a $45 million capital raise and a new API supply deal with Piramal.